John Murad Email & Phone Number

New York, NY, US

Global, Global, OO

Cytiva is a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics.

Stockholm, SE

• Head of North American operations and sales to include all CLIA lab operations and US | Canadian sales teams. Core business includes Oncology | Hereditary Diseases | Post Transplant.
• Led the first US partnership deal for Devyser with Cyted (Oncology) and Thermo Fisher distributing genomic testing products in North America.
• Lead biopharma business development, marketing strategy and several B2B pharma partnerships.
• Grew North America sales by 285% in 2023 to include US and Canada.
• Launched and lead commercial strategy for the first US CLIA laboratory for Deyvser in June 2023.

South San Francisco, CA, US

• Promoted from Regional Director to launch new Business Unit in April 2021.
• Hired and developed National Pulmonology Sales strategy and structure for the national team of 31 Pulmonology Sales Specialists and four Regional Sales Directors.
• Created first IDN | National Account and Inside Sales Team strategies for Veracyte.
• Grew Oncology | Pulmonology Business 38% FYTD 2022 vs 2021 across both products combined.
• Established cadence and partnerships with key internal stakeholders including GM, Pulmonology & Oncology Leadership Team, marketing, finance, R&D, medical, client services and extended team leaders.
• Selected by executive leadership to lead the Corporate Culture and Collaboration Integration Team in 2022.

South San Francisco, CA, US

• Led Northeast Sales and strategy for oncology team of 12 Sales Specialists selling Afirma (Thyroid Cancer), Percepta (Lung Cancer) and Envisia (ILD) genomic sequencing classifiers.
• Promoted to National Sales Director in April 2021.
• Drove consistent double-digit sales growth for 2 consecutive years as the leading national region.

Abbott Park, Illinois, US

• Lead National Account, Distribution Partnerships and Marketing for the US Outpatient POC Sales Team.
• Developed 2018 National Account sales strategy to include Biopharma, Oncology, and IDN markets.
• Led Abbott POC corporate strategy to optimize distribution partnerships and contracts.
• Created and launched a more efficient demand planning and forecasting process for the sales team.
• Drove 12% growth in 2018 in sales through US distribution programs and national account strategies.
• Led National Account team to 148% of sales plan and 32% increase in growth for 2018.

Abbott Park, Illinois, US

• Managed full P&L and a $20M budget for US sales and marketing, leading a team of 10 with $460M in US annual sales.
• Created a Value Analysis Committee solution which provided the sales team with metrics to communicate the financial impact of value-based purchasing and the reimbursement impacts of POC testing.
• Successfully executed the CMS PAMA/MACRA/MIPS commercial strategy for the implementation of Commercial Channel messaging and achieving reimbursement revenue for POC testing.
• Finished 2017 at 105% of the US Sales Plan and achieved 10% Growth for Piccolo in 2017.
• Developed and launched commercial sales and marketing strategies to protect the customer base and address the reimbursement reductions due to the implementation of PAMA in 2018.

Abbott Park, Illinois, US

• Redesigned, staffed, and developed the $100M POC Channel Marketing organization, introducing new customer segments which all achieved double-digit growth in 3 consecutive years.
• Spearheaded reimbursement and customer-targeting projects to improve operational sales.
• Presented at the 2016 US Biodefense conference on POC testing in emergencies.
• Selected by the Abbott Diagnostics Division President to lead the $5.2B commercial integration of Alere in 2016 which was successfully merged in 2017.
• Drove 14% overall sales growth, 74% capital growth and achieved 103% sales plan in 2015.
• Drove double-digit growth for key strategic distribution partners, McKesson and Henry Schein.

Abbott Park, Illinois, US

• Managed IVD (i-STAT and Piccolo) lines of business, meeting or exceeding the commercial financial plan for both products 2013-2015.
• Created Supplier-Driven Distribution strategy to drive partners more effectively to key customers.
• Developed strategies for emerging customer segments, such as oncology, hematology and long term care.
• Achieved three consecutive years of double-digit sales growth and annual sales plan attainment.
• Drove 12-22% sales growth annually from 2013 to 2015 for key POC distribution partners.

Abbott Park, Illinois, US

• Developed marketing plans and strategies for the Oncology and Primary Care Markets to include US Distribution Partnerships.
• Created the strategic marketing plan for the launch of Piccolo in a highly compressed timeframe; led all Piccolo sales training and created six workshops for the 2013 APOC National Sales Meeting.
• Developed new POC digital marketing strategies that included Salesforce.com, the Distribution RepConnect app, Physician Office Resource, and upgrades to the APOC website.
• Grew the POL i-STAT market from $19.5M in 2010 to $29.9M in 2013 through improved distribution relationships and strategic marketing programs.
• Won the 2012 Abbott POC Marketing Award for Excellence.

Cincinnati, Ohio, US

Pharmaceutical Division

Cincinnati, Ohio, US

Certificate | Navigating The Health Care Landscape - Executive Education Course, Business/Managerial Economics

Bs, Environmental Science